• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转化生长因子-β诱导的转录因子 Smad 非依赖性辅助性 T 细胞 17 的诱导是通过抑制 eomesodermin 实现的。

Transcription factor Smad-independent T helper 17 cell induction by transforming-growth factor-β is mediated by suppression of eomesodermin.

机构信息

Department of Microbiology and Immunology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan.

出版信息

Immunity. 2011 May 27;34(5):741-54. doi: 10.1016/j.immuni.2011.02.021. Epub 2011 May 19.

DOI:10.1016/j.immuni.2011.02.021
PMID:21600798
Abstract

Transforming growth factor-β (TGF-β) has been shown to be required for Th17 cell differentiation via Smad-independent mechanisms. The molecular mechanism underlying this pathway remains to be clarified, however. We searched for genes regulated by TGF-β through the Smad-independent pathway by using Smad2 and Smad3 double-deficient T cells and identified the transcription factor Eomesodermin (Eomes), whose expression was suppressed by TGF-β via the c-Jun N-terminal kinase (JNK)-c-Jun signaling pathway. Inhibition of JNK strongly suppressed disease in an in vivo EAE model as well as in vitro Th17 cell induction. Overexpression of Eomes substantially suppressed Th17 cell differentiation, whereas ablation of Eomes expression could substitute for TGF-β in Th17 cell induction in primary T cells. Eomes suppressed Rorc and Il17a promoters by directly binding to the proximal region of these promoters. In conclusion, the suppression of Eomes by TGF-β via the JNK pathway is an important mechanism for Smad-independent Th17 cell differentiation.

摘要

转化生长因子-β(TGF-β)已被证明通过 Smad 非依赖性机制对 Th17 细胞分化是必需的。然而,这一途径的分子机制仍有待阐明。我们通过使用 Smad2 和 Smad3 双重缺陷 T 细胞来寻找 TGF-β 通过 Smad 非依赖性途径调节的基因,并鉴定了转录因子 Eomesodermin(Eomes),其表达通过 c-Jun N 末端激酶(JNK)-c-Jun 信号通路被 TGF-β抑制。在体内 EAE 模型和体外 Th17 细胞诱导中,JNK 的抑制强烈抑制疾病。Eomes 的过表达显著抑制 Th17 细胞分化,而 Eomes 表达的缺失可替代 TGF-β在原代 T 细胞中诱导 Th17 细胞。Eomes 通过直接结合这些启动子的近端区域来抑制 Rorc 和 Il17a 启动子。总之,TGF-β 通过 JNK 途径抑制 Eomes 是 Smad 非依赖性 Th17 细胞分化的重要机制。

相似文献

1
Transcription factor Smad-independent T helper 17 cell induction by transforming-growth factor-β is mediated by suppression of eomesodermin.转化生长因子-β诱导的转录因子 Smad 非依赖性辅助性 T 细胞 17 的诱导是通过抑制 eomesodermin 实现的。
Immunity. 2011 May 27;34(5):741-54. doi: 10.1016/j.immuni.2011.02.021. Epub 2011 May 19.
2
Smad2 and Smad3 are redundantly essential for the TGF-beta-mediated regulation of regulatory T plasticity and Th1 development.Smad2 和 Smad3 在 TGF-β 介导的调节性 T 细胞可塑性和 Th1 细胞发育的调控中冗余地必不可少。
J Immunol. 2010 Jul 15;185(2):842-55. doi: 10.4049/jimmunol.0904100. Epub 2010 Jun 14.
3
Transforming growth factor beta signaling via Ras in mesenchymal cells requires p21-activated kinase 2 for extracellular signal-regulated kinase-dependent transcriptional responses.间充质细胞中通过Ras的转化生长因子β信号传导需要p21活化激酶2来实现细胞外信号调节激酶依赖性转录反应。
Cancer Res. 2007 Apr 15;67(8):3673-82. doi: 10.1158/0008-5472.CAN-06-3211.
4
SPARC regulates TGF-beta1-dependent signaling in primary glomerular mesangial cells.SPARC调节原代肾小球系膜细胞中转化生长因子-β1依赖性信号传导。
J Cell Biochem. 2004 Apr 1;91(5):915-25. doi: 10.1002/jcb.20008.
5
Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer.在连接区和COOH末端区域均发生磷酸化的Smad2和Smad3在人类结直肠癌晚期传递恶性转化生长因子-β信号。
Cancer Res. 2009 Jul 1;69(13):5321-30. doi: 10.1158/0008-5472.CAN-08-4203. Epub 2009 Jun 16.
6
TGF-beta-exposed plasmacytoid dendritic cells participate in Th17 commitment.TGF-β 暴露的浆细胞样树突状细胞参与 Th17 细胞的分化。
J Immunol. 2011 Jun 1;186(11):6157-64. doi: 10.4049/jimmunol.1002497. Epub 2011 Apr 25.
7
Chromatin immunoprecipitation on microarray analysis of Smad2/3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor beta signaling.基于微阵列分析的染色质免疫沉淀技术对Smad2/3结合位点的研究揭示了ETS1和TFAP2A在转化生长因子β信号传导中的作用。
Mol Cell Biol. 2009 Jan;29(1):172-86. doi: 10.1128/MCB.01038-08. Epub 2008 Oct 27.
8
Mechanisms of transforming growth factor beta(1)/Smad signalling mediated by mitogen-activated protein kinase pathways in keloid fibroblasts.丝裂原活化蛋白激酶通路介导的转化生长因子β(1)/Smad 信号转导在瘢痕成纤维细胞中的作用机制。
Br J Dermatol. 2010 Mar;162(3):538-46. doi: 10.1111/j.1365-2133.2009.09511.x. Epub 2009 Sep 2.
9
Smad4-independent TGF-beta signaling in tumor cell migration.肿瘤细胞迁移中不依赖Smad4的TGF-β信号传导
Cells Tissues Organs. 2007;185(1-3):123-30. doi: 10.1159/000101313.
10
(-)-Epigallocatechin gallate reduces transforming growth factor beta-stimulated HSP27 induction through the suppression of stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts.(-)-表没食子儿茶素没食子酸酯通过抑制成骨细胞中应激激活蛋白激酶/c-Jun氨基末端激酶,减少转化生长因子β刺激的HSP27诱导。
Life Sci. 2008 May 7;82(19-20):1012-7. doi: 10.1016/j.lfs.2008.02.017. Epub 2008 Mar 8.

引用本文的文献

1
Th17 cell pathogenicity in autoimmune disease.自身免疫性疾病中Th17细胞的致病性。
Exp Mol Med. 2025 Sep 1. doi: 10.1038/s12276-025-01535-9.
2
Eomes-dependent mitochondrial regulation promotes survival of pathogenic CD4+ T cells during inflammation.Eomes 依赖性线粒体调控促进炎症期间致病性 CD4+T 细胞的存活。
J Exp Med. 2024 Feb 5;221(2). doi: 10.1084/jem.20230449. Epub 2024 Jan 8.
3
Genome-wide DNA methylation pattern in whole blood of patients with Hashimoto thyroiditis.桥本甲状腺炎患者全血中的全基因组 DNA 甲基化模式。
Front Endocrinol (Lausanne). 2023 Nov 24;14:1259903. doi: 10.3389/fendo.2023.1259903. eCollection 2023.
4
Eomesodermin expression in CD4T-cells associated with disease progression in amyotrophic lateral sclerosis.埃姆斯多德明在与肌萎缩侧索硬化症疾病进展相关的CD4 T细胞中的表达。
CNS Neurosci Ther. 2024 Apr;30(4):e14503. doi: 10.1111/cns.14503. Epub 2023 Oct 18.
5
Genetic deletion of c-Jun amino-terminal kinase 3 (JNK3) modestly increases disease severity in a mouse model of multiple sclerosis.基因敲除 c-Jun 氨基末端激酶 3(JNK3)可适度增加多发性硬化症小鼠模型的疾病严重程度。
J Neuroimmunol. 2023 Sep 15;382:578152. doi: 10.1016/j.jneuroim.2023.578152. Epub 2023 Jul 12.
6
Small molecule inhibitors of RORγt for Th17 regulation in inflammatory and autoimmune diseases.用于炎症和自身免疫性疾病中Th17调节的RORγt小分子抑制剂。
J Pharm Anal. 2023 Jun;13(6):545-562. doi: 10.1016/j.jpha.2023.05.009. Epub 2023 May 20.
7
Characterization of proteogenomic signatures of differentiation of CD4+ T cell subsets.CD4+T 细胞亚群分化的蛋白质基因组特征分析。
DNA Res. 2023 Feb 1;30(1). doi: 10.1093/dnares/dsac054.
8
Dysregulation of the immune response in TGF-β signalopathies.TGF-β 信号通路中免疫反应失调。
Front Immunol. 2022 Dec 9;13:1066375. doi: 10.3389/fimmu.2022.1066375. eCollection 2022.
9
Regulation of CD4 T Cell Responses by the Transcription Factor Eomesodermin.转录因子 Eomesodermin 对 CD4 T 细胞应答的调节。
Biomolecules. 2022 Oct 24;12(11):1549. doi: 10.3390/biom12111549.
10
Effect of IL-10 Deficiency on TGFβ Expression during Fatal Alphavirus Encephalomyelitis in C57Bl/6 Mice.IL-10 缺陷对 C57Bl/6 小鼠致死性甲病毒脑炎中 TGFβ 表达的影响。
Viruses. 2022 Aug 16;14(8):1791. doi: 10.3390/v14081791.